Ysios Capital

Get funding

Ysios Capital is a leading life sciences investor financing highly innovative companies worldwide.

Use: Go2Market;
Date closing: -
Amount: -
Industry focus: Health;
Total budget: 216M €
Entity type: Venture Capital
Vertical focus: biotechnology, emerging pharmaceuticals, healthcare and medical technology
Website: http://www.ysioscapital.com/

Status:
Open
Funding type: Equity investment;
Geographic focus: Europe;
Public/Private: Private
Stage focus: Seed; Series A; Series B;
Applicant target: Startup;

Add a Review Send question

Overview

Ysios Capital provides biotech ventures with the resources to develop novel therapies for indications with high unmet medical needs.

They invest in companies that will have a positive impact on patients and society and in companies bringing life-changing treatments to patients, with a focus on indications with high unmet need.

Ysios Capital has raised a total of €411.4M across 3 funds, their latest being Ysios BioFund III. This fund was announced on Jun 10, 2020 and raised a total of €216M.

Portfolio: Adcendo, Aelix, Amgen, Galecto.

Last updated on 2023-05-04 11:52